Dr. Dispenzieri - ASH 2008 - Primary Therapy with Bortezomib—the Role of Induction, Maintenance, and Re-Induction in Patients with High Risk Myeloma. Update of Results from E2A02
Angela Dispenzieri, MD Mayo Clinic Rochester, Minnesota USA
12.27.08
To view the video full screen, click on the small
button next to the volume control in the
lower right hand corner.
back
button next to the volume control in the
lower right hand corner.
print
related articles